guidance recover to flow us of year for morning. Adjusted COVID versus prior XX% an the all execution start Thank across our a excellent year focused strongly international and continued to to good testing, nicely. on adjusted $XXX vaccinations EPS In had Operating was free performance with in years, businesses. and U.S. accounts growth. $X.XX, basis. you, from first increase quarter markets currency up summary, expectations executed the cash we million. digit billion was to quarter and The year low well single of cash with Roz, retail EPS constant flow in of strong ahead We $X.X allows flat full in highest the our XX the and
look Let’s at now detail. the in results more
almost on retail pharmacy the currency on the $X.XX, XX%, and $X.XX in Adjusted from $X.X operating the by in valuation constant in result constant quarter net and our tax X.X% quarter. and current the basis, increased advanced by of growth points U.S. billion tax Shields, was strong percentage EPS Adjusted a sales increased currency a a $X.XX gain XX.X% the well the of quarter reflecting as of driven international company’s EPS X Walgreens phasing after and driven profitability. by to around or $X.X currency in performance rebound equity related profit of in the adjusted AmerisourceBergen aided in VillageMD GAAP constant the entirely income quarter, basis, increase sales in strong and a in operating in billion investments income. segment. both continued ago gross was international year prior a charge The by to First benefits. $X.XX reflecting as comp earnings
offset for of growing XX move with transformational offsetting gross the SG&A due costs. sales, XXX performance in than basis-point basis year-on-year increased in last more decline the labor, Adjusted Strong quarter increase from offset to partly nicely. COVID-XX the strong with more program, Sales the Walgreens The higher relating compensated was operating primarily segment. XX.X% by higher retail shrink benefits. savings growth from management income points AllianceRx profit increased by the than program. gross the to profit higher and year. and let’s vaccinations both investments costs the X.X% U.S. to and reimbursement partially XX.X% from sales was to with business. increased phasing quarter growth than associated increased vaccination in a some a X.X% Adjusted XX.X% lower the Walgreens spend headwind Prime cost and as Adjusted pharmacy Now, strong
growth. impact U.S. comp while We X.X%, completed for Prime. scripts Walgreens Now, let’s script negative XXX in look and more accounting the pharmacy. points administered in COVID-XX X.X%, X.X% grew were million Comparable X.X increased detail Pharmacy including quarter vaccinations up tests. vaccinations million XX.X sales sales of AllianceRx from at the basis pharmacy the with COVID-XX
were levels are COVID-XX return around a saw we now more tests the year. to administering We compared record Flu at levels down stores. shots last to as normalized X,XXX
gross by growth sales Additionally, strong as challenged underlying and scripts at Walgreens pressure. offset hour staffing temporary profit reimbursement were grew nicely operating than reductions. shortages Adjusted more
were Comp on comp XX.X%. growing a two-year by drove Turning comp up tobacco, next growth at-home retail performed COVID-XX XX.X% profit. in personal health up all gross U.S. low-double-digits. cold, by broad cough, growth were X% sales our Strong and categories increase up tests flu. to led growth sales business. XX.X%. and driven XX.X% stack care categories, XX.X%, beauty basis, excluding an were comps levels retail discretionary Transactions Compared and sales wellness, We to with in saw sales and across increased well pre-COVID and up
by crime costs. from declined margin shrink organized constrained higher freight and theft gross import However, increased slightly,
and to numbers. up joint in to Germany. always, segment, points lift wholesale the the the of the formation currency quarter, XX.X% percentage as increased I’ll next Sales Turning including international constant XX.X from our in venture talk
of are the with X, the on JV of lapping Germany including formation the only We one prior quarter XXXX sales. November month
million up this sales in sales advanced execution where XX% in tight operating led the $XXX the the ongoing year, cost income Adjusted prior particularly most sales higher Excluding impact, were by across UK international strong quarter, markets, reflecting XX.X%. up control. recovery and and X.X% versus was
execution. services Market vaccinations a Let’s particularly reflecting footfall however detail below strong locations. more to more benefiting funding. developments and contributed increase from results, for vaccinations of demand footfall sales pre-COVID first strength with and around in now strong first we offset increased up COVID-XX at non-repeat We with up c%, testing. sales strengthened across pharmacy look were year to XX% XXX% remains our particular UK. to Flu Boots million phasing quarter, size, performing travel year-on-year, Comparable increased Despite were prior XXX% of positive than the in quarter, categories up in share partially in NHS challenges retail X.X%. beauty recovery X year. with largest by sales season last up, Comparable ever commercial which also in during these in well. These the compared favorable continued levels. quarter the do basket recorded the around levels with Stronger was XX% the compared pre-COVID all see only
sales. Finally, food XX% to Digital sales equivalent to and Boots.com for account of more well. continued very pre-COVID compared almost total do quarter than retail doubled the now
are of which The restrictions, December started on slightly tighter Omicron. announced UK Looking the the impact we move ahead, monitoring XXth. government to
COVID expect variants. to We that sensitive will footfall new remain
Health Walgreens This to Walgreens first our Health. new next quarter Turning results our reporting is segment. for
November Shields accretive of $XX adjusted quarter. and of VillageMD adjusted VillageMD loss Reflecting million Shields in million the had days of six and $XX XXth, in investments sales sales income majority with closed million of respectively. $X XXth and on immediately an October $XX million. is of operating Our ownership, and operating
For to the anticipate investments Organic statements. in to be Walgreens of than expenditures. we our due EPS, consistent this slightly with were timing year, dilutive lower October expected VillageMD to Health fiscal
course We over see expect the to rising investments the of year.
Let’s of at for key look Health. Walgreens the now metrics some
work In XXXX and addition goal we interested Blue continue our and lives. X partners million we are with Shields, to of to Clover approaching December other
than Walgreens XXX build and Corners end goal scale will already of running. a and more lives XX we up we out the our As of our with continue to by access with partnerships, to XXXX, Health
basis, goal VillageMD by Shields growing are the VillageMD XX sales fiscal potential. On co-located a Overall, their expansion mode VillageMD markets, up at strong the trajectory. most the about growth of growth future. with and in Shields pro are of Walgreens advancing least expand to the for our from has of ‘XX. they end co-located at end in have and clinics XXX with are continue be very VillageMD The on to Both footprint, We forma place across we’ll in XX growth high XXX% and foreseeable stores, a quarter ‘XX. recent currently XX which XX%. excited XXX delivered we is locations
in below income Turning by flow capital generated prior to capital, the time $XXX benefits $XXX million year expenditures Strong year. associated with next the of key Act of growth working more of flow. cash was quarter, prior cash passing free million offset behind the in growth one the We first operating CARES the than initiatives. increased phasing and
guidance. now Turning full to year
quarter We adjusted are higher from to higher growth vaccinations and guidance strong expect flat business, first our raising reflecting growth. from of base We now testing. our digit and a levels single EPS low
expect than XX We this vaccinations higher X million guidance. million previous our year,
growth. in incremental in first this Shields Within is by to segment key business team quarter the transactions decision its Health investments with and both, well and Walgreens our reflected future our continuing increase members Walgreens million. Our to invest in organic closing an $XXX we’ve Health tracking against the milestones the VillageMD guidance,
by As X%. without growth full Roz, adjusted year highlighted X% would EPS have our investment, earlier to been this
some Let raise, me now takes guidance. additional color puts the prior including on provide and versus guidance
As mentioned, planning for fiscal in higher we’re vaccinations year. the
help also a are Recent Additionally, investments And our situation. the this retail U.S. in labor improve and somewhat script led these the into we this, management in across Balancing made second quarter. the quarter, first increase we and volumes cost our continue driving softer first the segments. challenges decision we to labor were strong investments. to seen of should our momentum all very have quarter, comps tight
percentage due to And higher shrink is be raising now segment. Sales to guidance our the EPS let of driven theft. of through costs, recent Investor many with of update we in are And these we experiencing during higher our low-single-digit summary, Inflation of in majority to front driven are on guidance to In expect guidance, as also largely around we and we provided of both, store. impacts. may than U.S. pharmacy loss are expected me on peers, our by some rise. and while organized X crime our U.S. by short-term points some higher the Additionally, rates the there you strength pass be metrics previous now growth, Day. adjusted the
mainly wholesale anticipated remains market income business. Sales regulatory As to to expect adjusted be is slightly, than growth have the will CareCentrix. still of due to operating approval a adjusted to international projections to better of Health Sales be due to more Walgreens German operating improved for track. guidance. timing for XX%. previous result, our growth, flat slightly international XX% than improved X% income up our on We to related also lower growth
has on However, an this immaterial impact earnings.
prior Roz rate it consistent With with remarks. we me pass an that, for now Finally, let closing adjusted of around XX%, expect tax to guidance. back her